Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.3 (
complex I
)
8,901
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adipocyte triglyceride lipase (ATGL) is the major enzyme involved in the hydrolysis of triglycerides. The Arf1-coat protein
complex I
(COPI) machinery is known to be engaged in the recruitment of ATGL to lipid droplets (LDs), but the regulatory mechanism has not been clarified. In the present study, we found that
ELMOD2
, a putative noncanonical Arf-GTPase activating protein (GAP) localizing in LDs, plays an important role in controlling ATGL transport to LDs. We showed that knockdown of
ELMOD2
by RNA interference induced an increase in the amount of ATGL existing in LDs and decreased the total cellular triglycerides. These effects of
ELMOD2
knockdown were canceled by transfection of small interfering RNA-resistant cDNA of wild-type
ELMOD2
but not by that of mutated
ELMOD2
lacking the Arf-GAP activity.
ELMOD2
was distributed in the endoplasmic reticulum and mitochondria as well as in LDs, but palmitoylation was required only for distribution to LDs. An
ELMOD2
mutant deficient in palmitoylation failed to reconstitute the ATGL transport after the
ELMOD2
knockdown, indicating that distribution in LDs is indispensable to the functionality of
ELMOD2
. These results indicate that
ELMOD2
regulates ATGL transport and cellular lipid metabolism by modulating the Arf1-COPI activity in LDs.
...
PMID:ELMOD2 is anchored to lipid droplets by palmitoylation and regulates adipocyte triglyceride lipase recruitment. 2590 33